Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.

[1]  M. Gautel,et al.  Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. , 1999, Journal of molecular biology.

[2]  L. Leinwand,et al.  Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy. , 1998, Biophysical journal.

[3]  H. Watkins,et al.  Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Watkins,et al.  Defective inhibitory properties of human cardiac troponin I mutants that cause familial hypertrophic cardiomyopathy (FHC) , 1998 .

[5]  T. Hewett,et al.  A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. , 1998, The Journal of clinical investigation.

[6]  B. Hainque,et al.  Familial hypertrophic cardiomyopathy: from mutations to functional defects. , 1998, Circulation research.

[7]  A. Kisanuki,et al.  Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. , 1998, Circulation.

[8]  I. Ohtsuki,et al.  Ca2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy. , 1998, American journal of physiology. Cell physiology.

[9]  M. Komajda,et al.  Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. , 1998, Circulation.

[10]  H Niimura,et al.  Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. , 1998, The New England journal of medicine.

[11]  J. Seidman,et al.  Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. , 1998, The Journal of clinical investigation.

[12]  R. Jeremy,et al.  Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene. , 1998, Journal of medical genetics.

[13]  J. Moolman-Smook,et al.  Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy. , 1998, Journal of medical genetics.

[14]  Pascale Richard,et al.  Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy , 1998, Journal of Molecular Medicine.

[15]  B. Maron,et al.  A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. , 1998, Circulation research.

[16]  R. Solaro,et al.  The C Terminus of Cardiac Troponin I Is Essential for Full Inhibitory Activity and Ca2+ Sensitivity of Rat Myofibrils* , 1997, The Journal of Biological Chemistry.

[17]  R. Hodges,et al.  Mapping of a second actin-tropomyosin and a second troponin C binding site within the C terminus of troponin I, and their importance in the Ca2+-dependent regulation of muscle contraction. , 1997, Journal of molecular biology.

[18]  M. Matsuzaki,et al.  Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy , 1997, Nature Genetics.

[19]  H. Watkins,et al.  Effects of two hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility. , 1997, Biochemical and biophysical research communications.

[20]  W. Rottbauer,et al.  Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. , 1997, The Journal of clinical investigation.

[21]  A. Marian,et al.  Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. , 1997, Circulation research.

[22]  R. Hodges,et al.  Distinct Regions of Troponin I Regulate Ca2+-dependent Activation and Ca2+ Sensitivity of the Acto-S1-TM ATPase Activity of the Thin Filament* , 1997, The Journal of Biological Chemistry.

[23]  J. Seidman,et al.  Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function. , 1997, Biochemistry.

[24]  K. Chien,et al.  Point Mutations in Human β Cardiac Myosin Heavy Chain Have Differential Effects on Sarcomeric Structure and Assembly: An ATP Binding Site Change Disrupts Both Thick and Thin Filaments, Whereas Hypertrophic Cardiomyopathy Mutations Display Normal Assembly , 1997, The Journal of cell biology.

[25]  W. Mckenna,et al.  The management of hypertrophic cardiomyopathy. , 1997, The New England journal of medicine.

[26]  M. Komajda,et al.  Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. , 1997, Circulation research.

[27]  H. Watkins,et al.  Sudden death due to troponin T mutations. , 1997, Journal of the American College of Cardiology.

[28]  H. Sugi,et al.  Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication. , 1997, The Journal of clinical investigation.

[29]  M. Wróblewska-Kałużewska,et al.  [Familial hypertrophic cardiomyopathy]. , 1997, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[30]  M. Yacoub,et al.  Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. , 1996, Circulation.

[31]  M. Ikebe,et al.  Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome. , 1996, The Journal of clinical investigation.

[32]  J. Seidman,et al.  Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action. , 1996, The Journal of clinical investigation.

[33]  Y. Fujio,et al.  Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene. , 1996, Heart.

[34]  E. Homsher,et al.  Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy. , 1996, The Journal of clinical investigation.

[35]  Frederick J. Schoen,et al.  A Mouse Model of Familial Hypertrophic Cardiomyopathy , 1996, Science.

[36]  I. Rayment,et al.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle , 1996, Nature Genetics.

[37]  J. Beckmann,et al.  Cardiac myosin binding protein–C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[38]  J. Seidman,et al.  Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[39]  J. Seidman,et al.  Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. , 1995, Human molecular genetics.

[40]  T. Kishimoto,et al.  Novel missense mutation in α-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy , 1995 .

[41]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[42]  D. Mann,et al.  Expression of a Mutation Causing Hypertrophic Cardiomyopathy Disrupts Sarcomere Assembly in Adult Feline Cardiac Myocytes , 1995 .

[43]  T. Imaizumi,et al.  A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy. , 1995, Circulation.

[44]  K. Schwartz.  Familial hypertrophic cardiomyopathy. Nonsense versus missense mutations. , 1995, Circulation.

[45]  F. Reinach,et al.  The troponin complex and regulation of muscle contraction , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  M. Gautel,et al.  Phosphorylation switches specific for the cardiac isoform of myosin binding protein‐C: a modulator of cardiac contraction? , 1995, The EMBO journal.

[47]  I. Rayment,et al.  Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Seidman,et al.  Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.

[49]  A. Simcox,et al.  Impairment of muscle function caused by mutations of phosphorylation sites in myosin regulatory light chain , 1995, Nature.

[50]  L. Fananapazir,et al.  Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. , 1995, The Journal of clinical investigation.

[51]  A. Marian,et al.  Sudden cardiac death in hypertrophic cardiomyopathy , 1995 .

[52]  M. Le Cunff,et al.  The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments. , 1995, The Biochemical journal.

[53]  J. Towbin,et al.  Isolation of a de novo mutant myocardial beta MHC protein in a pedigree with hypertrophic cardiomyopathy. , 1994, Human molecular genetics.

[54]  J. Trewhella,et al.  A model structure of the muscle protein complex 4Ca2+.troponin C.troponin I derived from small-angle scattering data: implications for regulation. , 1994, Biochemistry.

[55]  Christine E. Seidman,et al.  α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.

[56]  P. Rogan,et al.  A new missense mutation, Arg719Gln, in the beta-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy. , 1994, Human molecular genetics.

[57]  F. Reinach,et al.  Functional alpha-tropomyosin produced in Escherichia coli. A dipeptide extension can substitute the amino-terminal acetyl group. , 1994, The Journal of biological chemistry.

[58]  C. Ramos,et al.  Structural and regulatory functions of the NH2- and COOH-terminal regions of skeletal muscle troponin I. , 1994, The Journal of biological chemistry.

[59]  L. Leinwand,et al.  Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. , 1994, The Journal of biological chemistry.

[60]  J. Seidman,et al.  Functional analysis of myosin missense mutations in familial hypertrophic cardiomyopathy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[61]  F. Reinach,et al.  The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif , 1993, The Journal of cell biology.

[62]  D A Winkelmann,et al.  Three-dimensional structure of myosin subfragment-1: a molecular motor. , 1993, Science.

[63]  W. Zhu,et al.  Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy. , 1993, The Journal of clinical investigation.

[64]  M. Dalakas,et al.  Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Spudich,et al.  Molecular evolution of the myosin family: relationships derived from comparisons of amino acid sequences. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[66]  A. Marian,et al.  Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy. , 1992, The Journal of clinical investigation.

[67]  J. Seidman,et al.  Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. , 1992, The Journal of clinical investigation.

[68]  L. Fananapazir,et al.  Differences in Clinical Expression of Hypertrophic Cardiomyopathy Associated With Two Distinct Mutations in the β‐Myosin Heavy Chain Gene: A 908Leu→Val Mutation and a 403Arg→gGln Mutation , 1992, Circulation.

[69]  M. Hatakenaka,et al.  Effect of removal and reconstitution of troponins C and I on the Ca(2+)-activated tension development of single glycerinated rabbit skeletal muscle fibers. , 1992, European journal of biochemistry.

[70]  J. Seidman,et al.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. , 1992, The New England journal of medicine.

[71]  E. Homsher,et al.  Factors affecting movement of F-actin filaments propelled by skeletal muscle heavy meromyosin. , 1992, The American journal of physiology.

[72]  M. Hatakenaka,et al.  Replacement of three troponin components with cardiac troponin components within single glycerinated skeletal muscle fibers. , 1991, Biochemical and biophysical research communications.

[73]  L. J. Bean,et al.  Phosphorylation of chicken cardiac C-protein by calcium/calmodulin-dependent protein kinase II. , 1991, The Journal of biological chemistry.

[74]  J. Seidman,et al.  A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.

[75]  R. Hodges,et al.  The biological importance of each amino acid residue of the troponin I inhibitory sequence 104-115 in the interaction with troponin C and tropomyosin-actin. , 1988, The Journal of biological chemistry.

[76]  E. Kranias,et al.  Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts. , 1988, The Biochemical journal.

[77]  I. Herskowitz.  Functional inactivation of genes by dominant negative mutations , 1987, Nature.

[78]  Y. Ishii,et al.  Fluorescence probe studies of the state of tropomyosin in reconstituted muscle thin filaments. , 1987, Biochemistry.

[79]  R. Bonow,et al.  Hypertrophic cardiomyopathy. , 1987, Disease-a-month : DM.

[80]  G. Phillips,et al.  Tropomyosin crystal structure and muscle regulation. , 1986, Journal of molecular biology.

[81]  H. C. Hartzell,et al.  Phosphorylation of purified cardiac muscle C-protein by purified cAMP-dependent and endogenous Ca2+-calmodulin-dependent protein kinases. , 1984, The Journal of biological chemistry.

[82]  H. C. Hartzell,et al.  Effects of cholinergic and adrenergic agonists on phosphorylation of a 165,000-dalton myofibrillar protein in intact cardiac muscle. , 1982, The Journal of biological chemistry.

[83]  S. Rosenfeld,et al.  Proteolytic fragments of troponin C. Interactions with the other troponin subunits and biological activity. , 1981, The Journal of biological chemistry.

[84]  R. Hodges,et al.  Synthetic studies on the inhibitory region of rabbit skeletal troponin I. Relationship of amino acid sequence to biological activity. , 1981, The Journal of biological chemistry.

[85]  S. A. Jeacocke,et al.  Phosphorylation of a myofibrillar protein of M r 150 000 in perfused rat heart, and the tentative identification of this as C‐protein , 1980, FEBS letters.

[86]  J. Besterman,et al.  The binding of skeletal muscle C-protein to F-actin, and its relation to the interaction of actin with myosin subfragment-1. , 1978, Journal of molecular biology.

[87]  J. Pringle.  The Croonian Lecture, 1977 - Stretch activation of muscle: function and mechanism , 1978, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[88]  S. Perry,et al.  The relationship between biological activity and primary structure of troponin I from white skeletal muscle of the rabbit. , 1976, The Biochemical journal.

[89]  Robert J. Krawczyk.  Properties of , 2000 .

[90]  H. Watkins.  Genotype: phenotype correlations in hypertrophic cardiomyopathy. , 1998, European heart journal.

[91]  J. Stull,et al.  Structural and functional responses of mammalian thick filaments to alterations in myosin regulatory light chains. , 1998, Journal of structural biology.

[92]  J. Seidman,et al.  Altered regulatory function of two FHC Troponin T mutants. , 1998 .

[93]  M. Gautel,et al.  A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. , 1996, European journal of biochemistry.

[94]  T. Mikawa,et al.  The carboxyl terminus of myosin binding protein C (MyBP-C, C-protein) specifies incorporation into the A-band of striated muscle. , 1996, Journal of cell science.

[95]  L. Fananapazir,et al.  Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. , 1994, Circulation.

[96]  M. Saraste,et al.  Structure and function of the SH3 domain. , 1994, Progress in biophysics and molecular biology.

[97]  S. Solomon,et al.  Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. , 1994, The Journal of clinical investigation.

[98]  J. Spudich,et al.  Assays for actin sliding movement over myosin-coated surfaces. , 1991, Methods in enzymology.

[99]  J. Potter,et al.  Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. , 1987, Annual review of biophysics and biophysical chemistry.

[100]  J. Spudich,et al.  Myosin structure and function in cell motility. , 1987, Annual review of cell biology.

[101]  W. Drabikowski,et al.  Proteolytic Fragments of Troponin C , 1981 .

[102]  R. Kretsinger,et al.  Structure and evolution of calcium-modulated proteins. , 1980, CRC critical reviews in biochemistry.